Menu Search
Equities

Datametrex AI Ltd

D4G:DUS

Datametrex AI Ltd

Actions
  • Price (EUR)0.0034
  • Today's Change0.000 / -5.56%
  • Shares traded40.00k
  • 1 Year change-90.00%
  • Beta--
Data delayed at least 15 minutes, as of Nov 11 2024 07:11 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.

  • Revenue in CAD (TTM)6.33m
  • Net income in CAD-20.90m
  • Incorporated2011
  • Employees30.00
  • Location
    Datametrex AI Ltd2300 Yonge Street, Suite 2802TORONTO M4P 1E4CanadaCAN
  • Phone+1 (416) 901-5611
  • Fax+1 (647) 400-8494
  • Websitehttps://www.datametrex.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.